Drugs / NPH/Regular 70/30 mix
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00821795 Comparator | Mar 2009 → Apr 2013 | type 2 diabetes mellitus | Dennis G. Karounos, M.D. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPH/Regular 70/30 mix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00821795 ↗ |
| Modality | Protein / enzyme biologic | “transition insulin therapy with NPH/Regular 70/30 mix for outpatient glycemic control following a hospitalization for non-critical acute illness” NCT00821795 ↗ |
| Route | Subcutaneous | “injectable solution, subcutaneous,0.3-0.5 units/kg/day divided into twice per day dosage, 16 weeks duration” NCT00821795 ↗ |